title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Intel  ( NASDAQ:INTC ) ,20240903T174109,https://www.benzinga.com/news/24/09/40693495/why-recursion-pharmaceuticals-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in,IOBT,0.090474,Somewhat-Bearish,-0.181123
68 Biggest Movers From Yesterday,20220405T103716,https://www.benzinga.com/news/22/04/26468849/68-biggest-movers-from-yesterday,IOBT,0.086348,Neutral,0.001016
"Cutaneous Melanoma Market is Predicted to Exhibit Remarkable Growth, Predicts DelveInsight | Key Companies - Merck, Amgen, Anaveon, Eisai, Regeneron, BMS, AstraZeneca, Seagen, Novartis, Eli Lilly and Company",20230724T210100,https://www.prnewswire.com/news-releases/cutaneous-melanoma-market-is-predicted-to-exhibit-remarkable-growth-predicts-delveinsight--key-companies---merck-amgen-anaveon-eisai-regeneron-bms-astrazeneca-seagen-novartis-eli-lilly-and-company-301883725.html,IOBT,0.02692,Neutral,0.029117
"Head and Neck Squamous Cell Carcinoma Market to Witness Upsurge in Growth by 2032, Assesses DelveInsight | Key Companies in the Market - Pfizer, Merck, Eisai, AstraZeneca, Innate, Roche, GlaxoSmithKline, BeiGene, IO Biotech, Incyte",20230918T210100,https://www.prnewswire.com/news-releases/head-and-neck-squamous-cell-carcinoma-market-to-witness-upsurge-in-growth-by-2032-assesses-delveinsight--key-companies-in-the-market---pfizer-merck-eisai-astrazeneca-innate-roche-glaxosmithkline-beigene-io-biotech-incyt-301930322.html,IOBT,0.023146,Neutral,0.04357
Medical Second Opinion Global Market to Register Stunning Growth at a CAGR of ~17% by 2028 | DelveInsight,20230821T210100,https://www.prnewswire.com/news-releases/medical-second-opinion-global-market-to-register-stunning-growth-at-a-cagr-of-17-by-2028--delveinsight-301905294.html,IOBT,0.024347,Neutral,-0.03954
